A new clinical tool may improve how physicians assess the severity of a painful and often debilitating skin disorder, ...

A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...

A new groundbreaking light therapy could kill cancer cells in just 30 minutes, scientists have discovered. In the new method, ...

Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...

WASHINGTON — Joe Biden recently underwent skin cancer surgery, a spokesperson confirmed to USA TODAY, just months after the former president was diagnosed with prostate cancer. According to the ...

The decision follows phase 3 trial data showing the immunotherapy cut disease recurrence or death risk by 68% in patients ...

Oct 8 (Reuters) - The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals’ (REGN.O), opens new tab immunotherapy, Libtayo, as an add-on treatment for skin cancer patients ...

Regeneron Pharmaceuticals' Libtayo won approval to treat certain patients with cutaneous squamous cell carcinoma, a type of skin cancer, from the Food and Drug Administration. The pharmaceutical ...

Torie Bosch is the First Opinion editor at STAT. When Joy Lisi Rankin’s mother was diagnosed with breast cancer, she made a decision many people, especially her doctors, did not understand: She ...

BREAST CANCER TREATMENT OPTIONS, AND DOCTORS SAY THEY’RE SEEING WOMEN LIVE LONGER. ONE OF THEM ARE DRUGS, WHICH ARE CALLED ANTIBODY DRUG CONJUGATES, WHICH ARE AN ANTIBODY THAT GOES AFTER A TARGET THAT ...

IceCure Medical’s tumor-freezing treatment ProSense has nabbed FDA approval, making it the first medical device of its kind to be endorsed for the local treatment of breast cancer. The Israeli medical ...

Every cell in the human body operates on an intricate internal schedule, governed by circadian rhythms that synchronize our biological processes with the 24-hour cycle of day and night. Coordinated by ...